None listed
Conditions
Brief summary
To test whether image guided radiotherapy for prostate carcinoma has less treatment related side effects and impairment of quality of life when an endorectal balloon is inserted during the radiotherapy compared to image guided radiotherapy alone.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Localised prostate cancer T1a - T3b, N0, M0 Any gleason score PSA equal to or less than 30 micrograms/L ECOG 0-2 Signed informed consent
Exclusion criteria
-Metastatic cancer of the prostate or disease involving organs such as the bladder and rectum - T4, N0,M0 -ECOG equal to or greater than 3. -Constant requirement for medication likely to interfere with evaluation of anorectal motility such as anti-diarrhoeal or opiate analgesic drugs. -Haemorrhoids greater than or equal to grade II (as evaluated using Common Terminology Criteria for Adverse Events V3.0 -Colitis equal to or greater than Grade II (as evaluated using Common Terminology Criteria for Adverse Events V3.0 -Any other anorectal disease that the clinician feels would interfere with the tolerance of the ERB during IGRT such as fissures, fistulas or abscesses. -Previous radiation therapy to the pelvis. - No signed informed consent